CMV infection is usually associated with concurrent HHV-6 and HHV-7 antigenemia in liver transplant patients

Journal of Clinical Virology

Volumn 25, Issue SUPPL. 2, 2002, Pages 57-61

  Lautenschlager, I ^a   Lappalainen, M ^a   Linnavuori, K ^a   Suni, J ^a   Hockerstedt K ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cytomegalovirus; Human herpesvirus 6; Human herpesvirus 7; Liver transplantation

Indexed keywords

GANCICLOVIR; MONOCLONAL ANTIBODY; PEROXIDASE; VIRUS ANTIGEN;

ADULT; ALLOGRAFT; ANTIBODY LABELING; ANTIGEN SPECIFICITY; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DRUG RESPONSE; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; LIVER GRAFT; LIVER TRANSPLANTATION; MONONUCLEAR CELL; PATIENT MONITORING; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; SYMPTOM; TREATMENT OUTCOME; VIRUS CULTURE; VIRUS DETECTION; VIRUS DIAGNOSIS;

EID: 0036701921     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1386-6532(02)00101-4     Document Type: Article

References (24)

1. Black J.B., Pellet P.E. Human herpesvirus 7. Rev. Med. Virol. 9:1999;245-262.
2. DesJardin J.A., Gibbon L., Cho E., Supran S.E., Falagas M.E., Werner B.G., et al. Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection. J. Infect. Dis. 178:1998;1783-1786.
3. Dockrell D.H., Prada J., Jones M.F., Patel R., Badley A.D., Harmsen W.S., et al. Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease. J. Infect. Dis. 176:1997;1135-1140.
4. Dockrell D.H., Paya C.V. Human herpesvirus-6 and -7 in transplantation. Rev. Med. Virol. 11:2001;23-36.
5. Emery V.C. Human herpesviruses 6 and 7 in solid organ transplant recipients. Clin. Infect. Dis. 32:2001;1357-1360.
6. Griffiths P.D., Ait-Khaled M., Bearcroft C.P., Clark D.A., Quagila A., Davies S.E., et al. Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus. J. Med. Virol. 59:1999;496-501.
7. Herbein G., Strasswimmer J., Altieri M., Woehl-Jaegle M.L., Obert G. Longitudinal study of human herpesvirus 6 infection in organ transplant recipients. Clin. Infect. Dis. 22:1996;171-173.
8. Humar A., Malkan G., Moussa G., Greig P., Levy G., Mazzulli T. Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients. J. Infect. Dis. 181:2000;1450-1453.
9. Lautenschlager I. Role of cytomegalovirus infection in the processes of organ allograft rejection: clinical studies and experimental models. Scholz M., Rabenau H.F., Doerr H.W., Cinatl J., CMV-related immunopathology. Monographs in virology. 1998;142-157 Karger AG, Basel.
10. Lautenschlager I., Höckerstedt K., Linnavuori K., Taskinen E. Human herpesvirus-6 infection after liver transplantation. Clin. Infect. Dis. 26:1998;702-707.
11. Lautenschlager I., Linnavuori K., Lappalainen M., Suni J., Höckerstedt K. HHV-6 reactivation is often associated with CMV infection in liver transplant patients. Transplant. Int. 13:2000a;S351-S353.
12. Lautenschlager I., Linnavuori K., Taskinen E., Höckerstedt K. Human herpesvirus-6 antigenemia after liver transplantation. Transplantation. 69:2000b;2561-2566.
13. Linnavuori K., Peltola H., Hovi T. Serology versus clinical signs or symptoms and main laboratory findings in the diagnosis of exanthema subitum infantum. Pediatrics. 89:1992;103-106.
14. Lusso P. Human herpesvirus 6 (HHV-6). Antivir. Res. 31:1996;1-21.
15. Mendez J.C., Dockrell D.H., Espy M.J., Smith T.F., Wilson J.A., Harmsen W.S., et al. Human β-herpesvirus interactions in solid organ transplant recipients. J. Infect. Dis. 183:2001;179-184.
16. Osman H.K.E., Peiris J.S.M., Taylor C.E., Warwicker P., Jarret R.F., Madeley C.R. Cytomegalovirus disease in renal allograft recipients: is human herpesvirus-7 a cofactor for disease progression? J. Med. Virol. 48:1996;295-301.
17. Santoro F., Kennedy P.E., Locatelli G., Malnati M.S., Berger E.A., Lusso P. CD46 is a cellular receptor for human herpesvirus 6. Cell. 99:1999;817-827.
18. Singh N., Carrigan D.R., Gayowski T., Marino I.R. Human herpesvirus-6 infection in liver transplant recipients. Documentation of pathogenicity. Transplantation. 64:1997;674-678.
19. Singh N. Human herpesviruses-6, -7 and -8 in organ transplant recipients. Clin. Microbiol. Infect. 6:2000;453-459.
20. Tanaka K., Kondo T., Torigoe S., Okada S., Mukai T., Yamanishi K. Human herpesvirus 7: another causal agent for roseola (exanthem subitum). J. Pediatr. 125:1994;1-5.
21. The T.H., van der Bij W., van der Berg A.P., van der Giessen M., Weits J., Sprenger H.G., et al. Cytomegalovirus antigenemia. Rev. Infect. Dis. 12:1990;S734-S744.
22. The T.H., van der Berg A.P., Harmsen M.C., van der Bij W., van Son W.J. The cytomegalovirus antigenemia assay: a plea for standardization. Scand. J. Infect. Dis. 99:(Suppl):1995;25-29.
23. Tong C.Y., Bakran A., Williams H., Cheung C.Y., Peiris J.S. Association of human herpesvirus 7 with cytomegalovirus disease in renal transplant recipients. Transplantation. 70:2000;213-216.
24. Yamanishi K., Okuno T., Shiraki K., Takahashi M., Kondo T., Asanao Y., et al. Identification of human herpesvirus-6 as causal agent for eaxanthem subitum. Lancet. I:1988;1065-1067.